Evidence map›Paper›PMID 22855498›Full record

ArticleJournal of virology2012

Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host.

Richard J P Brown, Natalia Hudson, Garrick Wilson, Shafiq Ur Rehman, Sara Jabbari, Ke Hu, Alexander W Tarr, Persephone Borrow, Michael Joyce, Jamie Lewis and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2019
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Animal models for the study of HCV.Current opinion in virology · 2015
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Richard J P BrownSchool of Molecular Medical Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, United Kingdom.
Natalia Hudson
Garrick Wilson
Shafiq Ur Rehman
Sara Jabbari
Ke Hu
Alexander W Tarr
Persephone Borrow
Michael Joyce
Jamie Lewis
Lin Fu Zhu
Mansun Law
Norman Kneteman
D Lorne Tyrrell
Jane A McKeating
Jonathan K Ball
University of Alberta · CAQueen's Medical Centre · GBUniversity of Birmingham · GBUniversity of Nottingham · GBJohn Radcliffe Hospital · GBKMT Hepatech (Canada) · CAScripps Research Institute · US

Funding

Understanding human neutralizing antibodies to hepatitis C virusR01AI079031 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI LAW, MANSUN · 2008 to 2017
$4.6M
Hepatitis C virus E2 glycoproteinR21AI080916 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI LAW, MANSUN · 2009 to 2010
$522k
CIHRMedical Research Council G0400802Medical Research Council G0801169Medical Research Council G0801976Medical Research Council G1100247NIAID NIH HHS R01 AI079031NIAID NIH HHS R01AI079031NIAID NIH HHS R21 AI080916NIAID NIH HHS R21AI080916
6 · The paper itself

Abstract

Genetic variability is a hallmark of RNA virus populations. However, transmission to a new host often results in a marked decrease in population diversity. This genetic bottlenecking is observed during hepatitis C virus (HCV) transmission and can arise via a selective sweep or through the founder effect. To model HCV transmission, we utilized chimeric SCID/Alb-uPA mice with transplanted human hepatocytes and infected them with a human serum HCV inoculum. E1E2 glycoprotein gene sequences in the donor inoculum and recipient mice were determined following single-genome amplification (SGA). In independent experiments, using mice with liver cells grafted from different sources, an E1E2 variant undetectable in the source inoculum was selected for during transmission. Bayesian coalescent analyses indicated that this variant arose in the inoculum pretransmission. Transmitted variants that established initial infection harbored key substitutions in E1E2 outside HVR1. Notably, all posttransmission E1E2s had lost a potential N-linked glycosylation site (PNGS) in E2. In lentiviral pseudoparticle assays, the major posttransmission E1E2 variant conferred an increased capacity for entry compared to the major variant present in the inoculum. Together, these data demonstrate that increased envelope glycoprotein fitness can drive selective outgrowth of minor variants posttransmission and that loss of a PNGS is integral to this improved phenotype. Mathematical modeling of the dynamics of competing HCV variants indicated that relatively modest differences in glycoprotein fitness can result in marked shifts in virus population composition. Overall, these data provide important insights into the dynamics and selection of HCV populations during transmission.

Indexed as

AnimalsBayes TheoremCell TransplantationEpitopesFounder EffectGenetic VariationGenomeGlycoproteinsHepatitis CHepatocytesHumansMiceMice, SCIDModels, TheoreticalPeptidesPhenotypeE1E2 peptideEpitopesGlycoproteinsPeptidesUrokinase-Type Plasminogen ActivatorViral Envelope Proteins

Identifiers

PMID22855498
PMCPMC3486514
OpenAlexW2055077060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.